Document:

EX-4.8

 Exhibit 4.8 

CERTAIN CONFIDENTIAL INFORMATION, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE (I) IT IS NOT MATERIAL AND (II) THE
REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THE INFORMATION AS PRIVATE AND CONFIDENTIAL. 
 THIS WARRANT (AS DEFINED BELOW) AND THE SECURITIES
ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY (AS DEFINED BELOW) THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT. 

			
	Date of Issuance	 	Void after
	March 13, 2021	 	April 11, 2025

 MARQETA, INC. 

WARRANT TO PURCHASE SHARES OF COMMON STOCK 

In connection with that certain Master Services Agreement, by and between Marqeta, Inc., a Delaware corporation (the “Company”), and
Square, Inc. (the “Holder”), dated as of August 19, 2016, as amended as of the date hereof (the “Commercial Agreement”), including without limitation that certain Amendment No. 12 to the Commercial Agreement, dated as
of even date hereof, and in consideration for the promises and agreements received thereto, the receipt and sufficiency of which is hereby acknowledged, this Warrant to Purchase Shares of Common Stock (this “Warrant”) is issued to the
Holder by the Company as of the date set forth above (the “Effective Date”). Terms used herein and capitalized, but not defined, shall have the meaning ascribed to them in the Commercial Agreement. 

 

	 	1.	 Purchase of Shares. 

(a)    Number of Shares. Subject to the terms and conditions set forth herein, including the Vesting Schedule (as
defined below), the Holder is entitled, upon surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify the Holder in writing), to purchase from the Company up to 1,100,000 fully paid and
nonassessable shares of the Company’s Common Stock, par value $0.0001 per share (the “Common Stock”), subject to appropriate adjustment for future stock splits, dividends, combinations, recapitalizations and the like with respect to
the Common Stock. 
 (b)    Exercise Price. The exercise price for the shares of Common Stock issuable pursuant
to this Section 1 (the “Shares”) shall be $0.01 per share (the “Exercise Price”). The Shares and the Exercise Price shall be subject to adjustment pursuant to Section 8 hereof. 

 

	 	2.	 Vesting; Reporting and Auditing. 

(a)     The Shares shall be eligible to vest and become exercisable under this Warrant in accordance with the vesting
schedule set forth on Exhibit A attached hereto (“Vesting Schedule”) and the following reporting and auditing provisions. 

(b)     The Holder shall provide the following written statements to the Company: 

 

	 	(i)	 [***]; 

  

	 	(ii)	 [***]; and 

(iii)     to the extent Holder (or an affiliate thereof) satisfies the applicable Vesting Milestones during a [***]
Measurement Period (each as defined in Exhibit A hereto), Holder shall indicate such satisfaction in the relevant written notice described in clause (b)(ii) hereof. 

Each of the foregoing statements shall contain reasonable backup detail regarding the Holder’s calculations with respect to the subject
matter of such statements and the statements referenced in clause (b)(iii) hereof shall be reviewed for accuracy and completeness by the controller or similar senior employee of Holder with knowledge of the matters. 

 (c)    Promptly following the Company’s receipt of notice
indicating Holder’s (or an affiliate thereof) satisfaction of the applicable Vesting Milestones (as defined in Exhibit A hereto), as required under clause (b)(iii) hereof, but no later than five (5) calendar days following such
receipt, the Company shall deliver to the Holder a written notice confirming or disputing such satisfaction. To the extent the Company confirms satisfaction of such Vesting Milestones, this Warrant shall be immediately exercisable with respect to
the Shares corresponding to the applicable [***] Measurement Period (as indicated in Exhibit A hereto), and such exercisable Shares shall be considered “Vested” hereunder. To the extent the Company disputes such satisfaction, the
Company and Holder shall attempt in good faith to negotiate a resolution of the dispute prior to pursuing other available remedies. If the Company fails to confirm or deny Holder’s satisfaction of the applicable Vesting Milestones within the
time period prescribed by this clause (c), the applicable Shares shall be deemed “Vested” hereunder and become immediately exercisable. 

(d)    During the term of this Warrant and for a period of [***], Holder shall [***], in each case, during the term of
this Warrant. 
 (e)    If the Company has reasonable belief that there is a material error in Holder’s reporting
required under this Section 2, the Company may, at its own cost and expense, cause a third-party audit and/or inspection to be made of the applicable Holder records and facilities [***]. The Company may not conduct such audits more frequently
than [***] (as measured from the Measurement Date) and may not commence any audits following the [***] anniversary of the Measurement Date. Any such audit shall be conducted by an independent auditor jointly selected by Company and the Holder. Any
audit and/or inspection shall be conducted during Holder’s regular business hours at Holder’s facilities with reasonable advance notice. Holder agrees to provide such designated audit or inspection team reasonable access to the relevant
Holder records and facilities. For the sake of clarity, audits may be conducted for and cover any calendar period starting on the Measurement Date and ending on the date on which the audit was initiated. To the extent an audit indicates a material
error in Holder’s reporting required under this Section 2, the Company and Holder shall, for a period of thirty (30) days following discovery of each material error, attempt in good faith to investigate the findings of the audit and
negotiate a resolution of any dispute regarding such material error prior to pursuing other available remedies. 

3.    Exercise Period. 

(a)    Certain Definitions. 

(i)    An “Acquirer” shall mean the person or entity acquiring the assets, liabilities, business, or voting
securities in the Corporate Transaction. 
 (ii)    A “Corporate Transaction” shall mean the consummation of
(x) an Asset Sale, as such term is defined in the Company’s current Amended and Restated Certificate of Incorporation on file with the Secretary of State of the State of Delaware (the “Restated Certificate”) or (y) an
Acquisition (as defined in the Restated Certificate); provided that the issuance of shares in the Company’s Initial Public Offering (as defined herein) shall not be deemed to be a Corporate Transaction. 

(iii)    An “Initial Public Offering” shall mean (x) the consummation of the first firm commitment
underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, covering the offer and sale by the Company of its equity securities, or (y) the direct listing or direct placement of
equity securities in a publicly traded exchange, in either case, as a result of or following which the equity securities of the Company shall be publicly held. 

(iv)    A “Liquidation Event” shall have the meaning set forth in the Restated Certificate. 

(b)    Subject to the provisions of this Section 3 and Section 2, this Warrant shall be exercisable, in whole or
in part, during the period commencing on the Effective Date and ending at 5:00 p.m. Pacific time on that date which is ten calendar days following the four (4) year anniversary of the Measurement Date, unless sooner deemed exercised pursuant to
the terms of this Warrant (the “Exercise Period”). 

  
 2 

 (c)    In the event of a Corporate Transaction in which the Acquirer
assumes all of the Company’s rights and obligations under the Commercial Agreement pursuant to the terms and conditions set forth therein, then, as part of such transaction, lawful provision shall be made so that the Holder shall thereafter be
entitled to receive upon exercise of this Warrant, during the period specified herein and upon payment of the Exercise Price then in effect, the number of shares of stock or other securities or property of the successor corporation resulting from
the Corporate Transaction which a holder of the Shares deliverable upon exercise of this Warrant would have been entitled to receive in such Corporate Transaction if this Warrant had been exercised immediately before such Corporate Transaction with
respect to such Shares, all subject to further adjustment as provided in this Section 3; and, in any such case, appropriate adjustment (as determined by the Company’s Board of Directors) shall be made in the application of the provisions
herein set forth with respect to the rights and interests thereafter of the Holder to the end that the provisions set forth herein (including provisions with respect to changes in and other adjustments of the number of Shares of the Holder is
entitled to purchase) shall thereafter be applicable, as nearly as possible, in relation to any shares of Common Stock or other securities or other property thereafter deliverable upon the exercise of this Warrant. 

(d)    In the event of (i) a termination of the Commercial Agreement for any reason pursuant to the terms and
conditions thereof, (ii) a Corporate Transaction in which the Acquirer does not assume all of the rights and obligations of the Company under the Commercial Agreement, or (iii) a Liquidation Event (each of (i) through (iii), a
“Termination Event”), the Company shall notify the Holder at least thirty (30) days prior to the consummation of such Termination Event in order to provide Holder with an opportunity to exercise this Warrant. Upon the consummation of
such Termination Event and after giving effect to such exercise (if any), any remaining Shares that have not yet Vested and/or for which this Warrant is not exercised shall no longer be exercisable and this Warrant shall automatically become null
and void. 
 (e)    In the event of an Initial Public Offering, any Shares that have not yet been exercised and this
Warrant shall continue in accordance with its terms. 
 4.    Method of Exercise. 

(a)    While this Warrant remains outstanding and exercisable in accordance with Section 3 above, the Holder may
exercise, in whole or in part, the purchase rights for vested Shares evidenced hereby. Such exercise shall be effected by: 

(i)    the surrender of this Warrant, together with a duly executed copy of the Notice of Exercise attached hereto, to
the Secretary of the Company at its principal office (or at such other place as the Company shall notify the Holder in writing); and 

(ii)    the payment to the Company of an amount equal to the aggregate Exercise Price for the number of Shares being
purchased. 
 (b)    Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close
of business on the day on which this Warrant is surrendered to the Company as provided in Section 4(a) above. At such time, the person or persons in whose name or names any certificate for the Shares shall be issuable upon such exercise as
provided in Section 4(c) below shall be deemed to have become the holder or holders of record of the Shares represented by such certificate. 

(c)    Promptly after the exercise of this Warrant in whole or in part, the Company at its expense will cause to be issued
in the name of, and delivered to, the Holder, or as such Holder (upon payment by such Holder of any applicable transfer taxes) may direct: 

(i)    a certificate or certificates for the number of Shares to which such Holder shall be entitled, and 

  
 3 

 (ii)    in case such exercise is in part only, a new warrant or
warrants (dated the date hereof) of like tenor, calling in the aggregate on the face or faces thereof for the number of Shares equal to the number of such Shares described in this Warrant minus the number of such Shares purchased by the Holder upon
all exercises made in accordance with Section 4(a) above. 
 (d)    If the Holder has not exercised this Warrant
prior to the expiration of the Exercise Period, all of the Shares subject to this Warrant (including any Shares that are Vested Shares) shall automatically be cancelled, and Holder shall have no further rights with respect to any such Shares. 

5.    Representations and Warranties of the Company. In connection with the transactions provided for herein, the
Company hereby represents and warrants to the Holder that: 
 (a)    Organization, Good Standing, and
Qualification. The Company is a corporation duly organized, validly existing, and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted. The Company
is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a material adverse effect on its business or properties. 

(b)    Authorization. Except as may be limited by applicable bankruptcy, insolvency, reorganization or similar laws
relating to or affecting the enforcement of creditors’ rights, all corporate action has been taken on the part of the Company, its officers, directors, and stockholders necessary for the authorization, execution and delivery of this Warrant.
The Company has taken all corporate action required to make all the obligations of the Company reflected in the provisions of this Warrant the valid and enforceable obligations they purport to be. The issuance of this Warrant will not be subject to
preemptive rights of any stockholders of the Company that have not otherwise been waived. The Company has authorized sufficient shares of Common Stock to allow for the exercise of this Warrant. 

(c)    Compliance with Other Instruments. The authorization, execution and delivery of this Warrant will not
constitute or result in a material default or violation of any law or regulation applicable to the Company or any material term or provision of the Company’s current Certificate of Incorporation or bylaws, or any material agreement or
instrument by which it is bound or to which its properties or assets are subject. 
 (d)    Valid Issuance of Common
Stock. The Shares, when issued, sold, and delivered in accordance with the terms of this Warrant for the consideration expressed therein, will be duly and validly issued, fully paid and nonassessable and, based in part upon the representations
and warranties of the Holder in this Warrant, will be issued in compliance with all applicable federal and state securities laws. 

6.    Representations and Warranties of the Holder. In connection with the transactions provided for herein, the
Holder hereby represents and warrants to the Company that: 
 (a)    Authorization. Holder represents that it has
full power and authority to enter into this Warrant. This Warrant constitutes the Holder’s valid and legally binding obligation, enforceable in accordance with its terms, except as may be limited by (i) applicable bankruptcy, insolvency,
reorganization, or similar laws relating to or affecting the enforcement of creditors’ rights and (ii) laws relating to the availability of specific performance, injunctive relief or other equitable remedies. 

(b)    Purchase Entirely for Own Account. The Holder acknowledges that this Warrant is entered into by the Holder
in reliance upon such Holder’s representation to the Company that this Warrant and the Shares (collectively, the “Securities”) will be acquired for investment for the Holder’s own account, not as a nominee or agent, and not with
a view to the resale or distribution of any part thereof, and that the Holder has no present intention of selling, granting any participation in or otherwise distributing the same. The Holder further represents that the Holder does not have any
contract, undertaking, agreement, or arrangement with any person to sell, transfer or grant participations to such person or to any third person, with respect to the Securities. 

  
 4 

 (c)    Disclosure of Information. The Holder acknowledges that it
has received all the information it considers necessary or appropriate for deciding whether to acquire the Securities. The Holder further represents that it has had an opportunity to ask questions and receive answers from the Company regarding the
terms and conditions of the offering of the Securities. 
 (d)    Investment Experience. The Holder is an
investor in securities of companies in the development stage and acknowledges that it is able to fend for itself, can bear the economic risk of its investment, and has such knowledge and experience in financial or business matters that it is capable
of evaluating the merits and risks of the investment in the Securities. If other than an individual, the Holder also represents it has not been organized solely for the purpose of acquiring the Securities. 

(e)    Accredited Investor. The Holder is an “accredited investor” within the meaning of Rule 501 of
Regulation D, as presently in effect, as promulgated by the Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “Act”). 

(f)    Restricted Securities. The Holder understands that the Securities are characterized as “restricted
securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without
registration under the Act, only in certain limited circumstances. In this connection, each Holder represents that it is familiar with Rule 144, as presently in effect, as promulgated by the SEC under the Act (“Rule 144”), and understands
the resale limitations imposed thereby and by the Act. 
 (g)    Further Limitations on Disposition. Without in
any way limiting the representations set forth above, the Holder further agrees not to make any disposition of all or any portion of the Shares unless and until the transferee has agreed in writing for the benefit of the Company to be bound by the
terms of this Warrant, including, without limitation, this Section 6, Section 22, and: 
 (i)    there is
then in effect a registration statement under the Act covering such proposed disposition and such disposition is made in accordance with such registration statement; or 

(ii)    the Holder shall have notified the Company of the proposed disposition and shall have furnished the Company with
a detailed statement of the circumstances surrounding the proposed disposition, and if reasonably requested by the Company, the Holder shall have furnished the Company with an opinion of counsel, reasonably satisfactory to the Company, that such
disposition will not require registration of such shares under the Act. It is agreed that the Company will not require opinions of counsel for transactions made pursuant to Rule 144. 

Notwithstanding the foregoing, the restrictions on the disposition of Shares set forth in this Section 6 shall not apply after the
Company’s Initial Public Offering (and following the expiration of any lock-up requirements in Section 22), provided, that the Holder shall still be required to comply with securities laws and
regulations applicable to the disposition of shares in a publicly traded company. 
 (h)    Legends. It is understood
that the Securities may bear the following legend: 
 “THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR
AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. 

THE SHARES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE
STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH AND MAY BE OBTAINED FROM THE SECRETARY OF THE COMPANY AT NO CHARGE. 

  
 5 

 THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A RIGHT OF FIRST REFUSAL OPTION IN
FAVOR OF THE COMPANY AND/OR ITS ASSIGNEE(S), AS PROVIDED IN THE BYLAWS OF THE COMPANY.” 

7.    State Commissioners of Corporations. THE SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS
WARRANT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION FOR SUCH SECURITIES PRIOR TO SUCH QUALIFICATION IS
UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION UNDER THE CALIFORNIA CORPORATIONS CODE. 

8.    Covenants of the Company. 

(a)    Notices of Record Date. In the event of any taking by the Company of a record of the holders of any class of
securities for the purpose of determining the holders thereof who are entitled to receive any dividend or other distribution, the Company shall mail to the Holder, at least ten (10) days prior to such record date, a notice specifying the date
on which any such record is to be taken for the purpose of such dividend or distribution. 
 (b)    Covenants as to
Exercise Shares. The Company covenants and agrees that all Shares that may be issued upon the exercise of the rights represented by this Warrant will, upon issuance in accordance with the terms hereof, be validly issued and outstanding, fully
paid and nonassessable, and free from all taxes, liens and charges with respect to the issuance thereof. The Company further covenants and agrees that the Company will at all times during the Exercise Period, have authorized and reserved, free from
preemptive rights, a sufficient number of shares of Common Stock to provide for the exercise of the rights represented by this Warrant. If at any time during the Exercise Period the number of authorized but unissued shares of Common Stock shall not
be sufficient to permit exercise of this Warrant, the Company will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be
sufficient for such purposes. 
 9.    Adjustment of Exercise Price and Number of Shares. The number and kind of
Shares purchasable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows: 

(a)    Subdivisions, Combinations and Other Issuances. If the Company shall at any time after the issuance but
prior to the expiration of this Warrant subdivide its Common Stock, by split-up or otherwise, or combine its Common Stock, or issue additional shares of its Preferred Stock or Common Stock as a dividend with
respect to any shares of its Common Stock, the number of Shares issuable on the exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately decreased in the case of a
combination. Appropriate adjustments shall also be made to the Exercise Price payable per share, but the aggregate Exercise Price payable for the total number of Shares purchasable under this Warrant (as adjusted) shall remain the same. Any
adjustment under this Section 9(a) shall become effective at the close of business on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon the
making of such dividend. 
 (b)    Reclassification, Reorganization and Consolidation. In case of any
reclassification, capital reorganization or change in the capital stock of the Company (other than as a result of a subdivision, combination or stock dividend provided for in Section 9(a) above), then, as a condition of such reclassification,
reorganization or change, lawful provision shall be made, and duly executed documents evidencing the same from the Company or its successor shall be delivered to the Holder, so that the Holder shall have the right at any time prior to the expiration
of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind and amount of shares of stock and other securities or property receivable in connection with such reclassification, reorganization or
change by a holder of the same number and type of securities as were purchasable as Shares by the Holder immediately prior to such reclassification, reorganization or change. In any such case appropriate provisions shall be made with respect to the
rights and interest of the Holder so that the provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities or property deliverable upon exercise hereof, and appropriate adjustments shall be made to the
Exercise Price per Share payable hereunder, provided the aggregate Exercise Price shall remain the same. 

  
 6 

 (c)    Notice of Adjustment. When any adjustment is required to
be made in the number or kind of shares purchasable upon exercise of the Warrant, or in the Exercise Price, the Company shall promptly notify the Holder of such event and of the number of Shares or other securities or property thereafter purchasable
upon exercise of this Warrant. 
 10.    No Fractional Shares or Scrip. No fractional shares or scrip
representing fractional shares shall be issued upon the exercise of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise Price then in effect. 

11.    No Stockholder Rights. Prior to exercise of this Warrant, the Holder shall not be entitled to any rights of
a stockholder with respect to the Shares, including (without limitation) the right to vote such Shares, receive dividends or other distributions thereon, exercise preemptive rights or be notified of stockholder meetings, and, except as otherwise
provided in this Warrant, such Holder shall not be entitled to any stockholder notice or other communication concerning the business or affairs of the Company. 

12.    Transfer of Warrant. Other than in connection with a Corporate Transaction, this Warrant shall not be
transferable by the Company or the Holder without the prior written consent of the other party; provided that the Holder may transfer this Warrant to a controlled affiliate of the Holder; provided, further that such controlled affiliate agrees to be
bound by all of the terms and conditions of this Warrant; and provided, further that Holder and its controlled affiliate each execute written transfer documentation in a form reasonably acceptable to the Company. 

13.    Governing Law. This Warrant shall be governed by and construed under the laws of the State of Delaware as
applied to agreements among Delaware residents, made and to be performed entirely within the State of Delaware. 

14.    Successors and Assigns. The terms and provisions of this Warrant and the Commercial Agreement shall inure to
the benefit of, and be binding upon, the Company and the holders hereof and their respective successors and assigns. 

15.    Dispute Resolution. Any dispute with respect to this Warrant and the terms and conditions hereof (including
the achievement of any Vesting Milestone (as defined in Exhibit A hereto)) shall be determined pursuant to the dispute resolution provisions set forth in Section 15 of the Commercial Agreement. 

16.    Titles and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are
not to be considered in construing or interpreting this Warrant. 
 17.    Notices. All notices and other
communications given or made pursuant hereto shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal
business hours of the recipient, and if not so confirmed, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit
with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the respective parties at the following addresses (or at such other addresses as shall be
specified by notice given in accordance with this Section 17): 
 If to the Company: 

Marqeta, Inc. 
 180 Grand Avenue

 Oakland, CA 94612 

Attention: General Counsel 

Email: [***] 

  
 7 

 With a copy (which shall not constitute notice) to: 

Caine Moss 
 Goodwin Procter LLP

 601 Marshall Street 
 Redwood
City, CA 94063 
 Email: [***] 

If to Holder: 
 Square, Inc. 

1455 Market Street, Suite 600 

Attn: Legal 
 San Francisco, CA
94103 
 Email: [***] 

18.    Finder’s Fee. Each party represents that it neither is or will be obligated for any finder’s fee
or commission in connection with this transaction. The Holder agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder’s fee (and the costs and expenses of defending
against such liability or asserted liability) for which the Holder or any of its officers, partners, employees or representatives is responsible. The Company agrees to indemnify and hold harmless the Holder from any liability for any commission or
compensation in the nature of a finder’s fee (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible. 

19.    Expenses. If any action at law or in equity is necessary to enforce or interpret the terms of this Warrant,
the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled. 

20.    Entire Agreement; Termination, Amendments and Waivers. This Warrant, the Commercial Agreement, and any other
documents delivered pursuant hereto constitute the full and entire understanding and agreement between the parties with regard to the subject matter hereof and thereof. Nonetheless, any term of this Warrant may be amended and the observance of any
term of this Warrant may be waived (either generally or in a particular instance and either retroactively or prospectively), solely with the written consent of the Company and the Holder. Notwithstanding the foregoing, this Warrant may be terminated
by the Company or the Holder by written notice to the other party for Cause (as described in the Commercial Agreement). 

21.    Severability. If any provision of this Warrant is held to be unenforceable under applicable law, such
provision shall be excluded from this Warrant and the balance of this Warrant shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms. 

22.    “Market Stand-Off’ Agreement. The Holder hereby agrees
that the Holder shall not sell, transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale, any Common Stock (or other securities) of the Company
held by the Holder immediately prior to the effectiveness of the registration (other than those included in the registration) during the 180-day period following the effective date of the Company’s
Initial Public Offering (or such longer period, not to exceed 34 days after the expiration of the 180-day period, as the underwriters or the Company shall request in order to facilitate compliance with FINRA
Rule 2241 or any successor or similar rule or regulation); provided, that all officers and directors of the Company are bound by and have entered into similar agreements and the Company shall use its best efforts to ensure that all holders of at
least one percent (1%) of the Company’s voting securities are bound by and have entered into similar agreements. 

23.    Clarification Regarding Start and End Times of Periods. Unless otherwise indicated herein, all periods
referred to hereunder shall begin at 12:00 AM UTC on the start date of such period and end at 11:59 PM UTC on the end date of such period. 

  
 8 

 IN WITNESS WHEREOF, the parties have executed this Warrant to Purchase Common Stock as of
the date first written above. 
  

					
		 	MARQETA, INC.
			
		 	By:	 	 /s/ Tripp Faix    

		 	Name:	 	 Tripp Faix    

		 	Title:	 	 CFO    

		
	Address:	 	180 Grand Avenue
		 	Oakland, CA 94612

 ACKNOWLEDGED AND AGREED: 

HOLDER 
 SQUARE, INC. 

 

			
	By:	 	 /s/ Brian Grassadonia    

	Name:	 	 Brian Grassadonia    

	Title:	 	 Square Cash
Lead    

			
		
	Address:	 	 1455 Market Street    

		 	 San Francisco, CA 94103    

 [Signature Page to Warrant] 

 NOTICE OF EXERCISE 

MARQETA, INC. 
 Attention: Corporate Secretary 

The undersigned hereby elects to purchase, pursuant to the provisions of the Warrant to Purchase Common Stock (the “Warrant”), as
follows: 
  

	☐	
                    shares of
Common Stock pursuant to the terms of the attached Warrant, and tenders herewith payment in cash of the Exercise Price of such Shares in full, together with all applicable transfer taxes, if any. 

 

	☐	 Net Exercise the attached Warrant with respect to
                    Shares. 

The undersigned hereby represents and warrants that Representations and Warranties in Section 6 hereof are true and correct as of the
date hereof. 
  

											
		 		 		 		 	HOLDER:
						
	Date:	 	  
	 		 		 	By:	 	 
					
		 		 		 	Address:	 	  

		 		 		 		 	  

		 		 		 		 	  

				
	Name in which shares should be registered:	 		 		 	
				
	  
	 		 		 	

 ASSIGNMENT FORM 

(To assign the foregoing Warrant to Purchase 

Common Stock (the “Warrant”), execute this 

form and supply required information. Do 

not use this form to purchase shares.) 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to 

 

			
	Name:	 	  

	  
	 	(Please Print)

			
		
	Address:	 	  

		 	(Please Print)

  

			
	Dated:	 	  

			
		
	Holder’s	 	  

			
	Signature:	 	  

		
	Holder’s	 	

			
	Address:	 	  

 NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant.
Officers of corporations and those acting in a fiduciary or other representative capacity should provide proper evidence of authority to assign the foregoing Warrant. 

 EXHIBIT A 

Vesting Schedule 

(a)    Vesting Milestones. The number of Shares eligible to vest and become exercisable in a given [***]
Measurement Period are indicated in Table I below. Subject to the requirements of Section 2 hereof, so long as [***], Shares will be eligible to vest and become exercisable [***] if the following vesting milestones (the “Vesting
Milestones”) are achieved: 
 (i)    in any given [***] Measurement Period, Holder [***] during such period;
and 
 (ii)    in a given [***] Measurement Period during [***] following the Measurement Date, as further
described in Table 1, Holder [***] during such period; or 
 (iii)    in a given [***] Measurement Period during
[***] following the Measurement Date, as further described in Table 1, [***] during such period; or 
 (iv)    in
a given [***] Measurement Period during [***] following the Measurement Date, as further described in Table 1, Holder [***] during such period. 

(b)    Definitions. As used in this Exhibit A, the following terms shall have the following meanings: 

(i)    “Measurement Date” means the first day of the first calendar month following the Date of Issuance.

 (ii)  [***]. 

(iii) [***]. 
 (iv) [***]. 

 Table I 
  

					
	 EVENT
	 	 DATE
	 	 NUMBER OF
SHARES ELIGIBLE
TO VEST

	Effective Date	 	March 13, 2021	 	N/A
	Measurement Date	 	April 1, 2021	 	N/A
	[***]	 	[***]	 	[***]
	[***]	 	[***]	 	[***]
	[***]	 	[***]	 	[***]
	[***]	 	[***]	 	[***]
	[***]	 	[***]	 	[***]
	[***]	 	[***]	 	[***]
	[***]	 	[***]	 	[***]
	[***]	 	[***]	 	[***]
	[***]	 	[***]	 	[***]
	[***]	 	[***]	 	[***]
	[***]	 	[***]	 	[***]
	[***]	 	[***]	 	[***]
	Expiration of the Warrant	 	April 11, 2025	 	N/AEX-10.8

 Exhibit 10.8 
  

 
 June 6, 2011 

Jason Gardner 
 [***] 

Re:    Employment Terms 

Marqeta, Inc. (the “Company”) is pleased to offer you the position of Chief Executive Officer on the following terms. 

1.    Duties. You will be responsible for duties as are ordinary, customary and necessary in your role as Chief
Executive Officer. 
 2.    Compensation. Your initial base salary will be at an annual rate of $180,000, less
payroll deductions and all required withholdings (“Base Salary”). Your compensation package (including, but not limited to, base salary and bonus) will be reviewed at the end of each calendar year as part of the Company’s normal
compensation review process. In addition, you will receive reimbursement for any travel expenses previously approved by the Chief Executive Officer in writing (including, but not limited to, electronic mail). 

3.    Standard Benefits. You will be paid bi-weekly and you will be
eligible for the standard Company benefits, including, but not limited to, family medical care and disability insurance coverage. Details about these benefit plans will be available for your review as they are adopted. The Company may modify
compensation and benefits from time to time, as it deems necessary. 
 4.    Rules and Policies. As a Company
employee, you will be expected to abide by Company rules and policies as they are adopted and amended from time to time and sign and comply with the attached Proprietary Information and Inventions Agreement which prohibits unauthorized use or
disclosure of the Company’s proprietary information and solicitation of its employees and customers. 

5.    Proprietary Information. In your work for the Company, you will be expected not to use or disclose any
confidential information, including trade secrets, of any former employer or other person to whom you have an obligation of confidentiality. Rather, you will be expected to use only that information which is generally known and used by persons with
training and experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company. During our discussions about your proposed job duties,
you assured us that you would be able to perform those duties within the guidelines just described. You agree that you will not bring onto the Company’s premises any unpublished documents or property belonging to any former employer or other
person to whom you have an obligation of confidentiality. 

  
 1 

 6.    At-Will Employment.
Your employment at the Company is “at-will.” You may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying the Company. Likewise, the Company may
terminate your employment at any time and for any reason whatsoever, with or without cause or advance notice. As required by law, this offer is subject to satisfactory proof of your right to work in the United States. As an exempt salaried employee,
you will be expected to work additional hours as required by the nature of your work assignments. 

7.    Miscellaneous. This letter, together with your Proprietary Information and Inventions Agreement, forms the
complete and exclusive statement of your employment agreement with the Company. The employment terms in this letter supersede any other agreements or promises made to you by anyone, whether oral or written. This letter agreement cannot be changed
except in a writing signed by you and a duly authorized officer of the Company. 
 Please sign and date this letter, and return it to me if
you wish to accept employment at the Company under the terms described above. If you accept our offer, we would like you to start on Monday June 6, 2011. 

We look forward to your favorable reply and to a productive and enjoyable work relationship. 

Sincerely, 
 Marqeta, Inc. 

 

	
	 /s/ Jason Gardner

	Jason Gardner
	 Chief Executive Officer

 Accepted: 
  

					
	 /s/ Jason Gardner
	    	 6/6/2011
	  	
	Jason Gardner	    	Date	  	

 Attachment: Proprietary Information and Inventions Agreement 

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}]]